Delivery Order SPE2DB25D3306-SPE2DB25FUALD

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,586.44 firm fixed-price delivery order is for the supply of 4565666593 YONSA 125 MG TABLET 120S, with a period of performance through September 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,195.48 firm fixed-price contract is for the supply of YONSA 125 MG TABLET 120S, a specialty pharmaceutical product. The contract has a period of performance through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order with a ceiling value of $2,195.48 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of YONSA 125 MG TABLET 120S, a medication, with a period of performance through November 18, 2024. The contract type is Firm Fixed Price. This award is not associated with any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is a Firm Fixed Price Delivery Order for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $4,390.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of February 21, 2024. The contract is a firm fixed price delivery order and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $2,195.48, is for the delivery of 4565843570 YONSA 125 MG TABLET 120S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide...
This federal contract award is for the delivery of 120 tablets of the pharmaceutical product YONSA 125 MG. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,195.48 and a completion date of February 16, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating...
This federal contract award, valued at $2,195.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The contract is for the delivery of YONSA 125 MG TABLET 120S, a prescription medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUALD
    Delivery Order

This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a performance period running through January 24, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

The contract award did not utilize any set-aside designations, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 4/3/25, 11:18 AM